These risks and uncertainties include and are not limited to the following: (i) we have incurred significant losses since inception, we expect to incur significant losses in the future and we may not be able to generate sufficient revenue to achieve and maintain profitability; (ii) we have very little history manufacturing and commercializing our products or technology; (iii) the life sciences technology market is highly competitive, and if we fail to compete effectively, our business and operating results will suffer; (iv) if we are sued for infringing, misappropriating or otherwise violating intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our products; (v) if our products fail to achieve early customer and scientific acceptance, we may not be able to achieve broader market acceptance for our products, and our revenues and prospects may be harmed; (vi) we expect to be highly dependent upon revenue generated from the sale of the G4 and planned PX, and any delay or failure by us to successfully manufacture and commercialize the G4 and planned PX could have a substantial adverse effect on our business and results of operations; and (vii) the COVID-19 pandemic, efforts to reduce its spread and recent macroeconomic challenges have adversely impacted, and may materially and adversely impact, our business, operations and product manufacturing and commercialization objectives. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. You might be interested in: Digihost Technology Shares Down 4.2%. Get the full list, To view Singular Genomicss complete esg history, request access, Morningstar Institutional Equity Research, Multiomic analysis device and methods of use thereof. Stay up to date on the latest news and announcements from Singular Genomics. When autocomplete results are available use up and down arrows to review and enter to select. The average price target represents a 118.45% change from the last price of $1.03. The company can be reached via phone at 858-333-7830. Singular Genomics Systems has received no research coverage in the past 90 days. Touch device users, explore by touch or with swipe gestures. Singular Genomics Systems, Inc. (Name of Issuer) Common Stock par value $0.0001 per share (Title of Class of Securities) 82933R100 . Singular Genomics' Contacts. All rights reserved. Owning 46% shares,institutional owners seem interested in Singular Genomics Systems, Inc. (NASDAQ:OMIC), Eli Glezer Is The Founder of Singular Genomics Systems, Inc. (NASDAQ:OMIC) And They Just Picked Up 1.2% More Shares, A Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider increased their holdings by 16% last year, Singular Genomics Systems, Inc. (OMIC) Q3 2022 Earnings Call Transcript, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Apple To $220? Research & Science Based on 39 salaries Scientist II 5 salaries Scientist 5 salaries View More Engineering Based on 11 salaries QC Associate II 2 salaries Sr Engineer window.hsFormsOnReady.push(()=>{ Minimum 15 minutes delayed. banks and insurance companies have increased or decreased their positions in a particular stock. Defense. Singular Genomics Systems has a P/B Ratio of 0.30. We are purposeful and collaborative in our approach. Singular Genomics Systems Inc P/B ratio is 0.2981. Data is subject to change. Since then, OMIC stock has decreased by 46.3% and is now trading at $1.08. Its calculated by dividing the current share price by the earnings per share (or EPS). Operating expenses included non-cash stock-based compensation expense of $13.7million in 2022 and $9.2 million in 2021. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Please log in to your account or sign up in order to add this asset to your watchlist. Industry News. We are advancing genomics, together. ET). 3, 2022 at 10:25 a.m. On average, they predict the company's stock price to reach $3.50 in the next year. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating. These symbols will be available throughout the site during your session. Follow Us. Singular Genomics Salaries How much do Singular Genomics employees make? Raising the bar with industry-leading run times across applications. We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. It's calculated by averaging the closing stock price over the previous 50 trading days. (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. amount that a seller is currently willing to sell. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The low in the last 52 weeks of Singular Genomics Systems stock was 1.08. Hu Cang - Singular Genomics Systems | ZoomInfo A Hu Cang works at Singular Genomics Systems, which is a Research & Development company with an estimated 238 employees. Singular Genomics stock price target cut to $15 from $25 at UBS. Read Less. The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. View the best growth stocks for 2023 here. Singular Genomics Systems Inc market cap is $77.7M. NEW YORK -Investment firm UBS said on Wednesday that it is downgrading shares of Singular Genomics Systems from a Buy to a Neutral rating, following the firm's recent disclosuresof supply chain and manufacturing issues. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. The numbers next to the bid/ask are the size. After all, the newsletter they have run for over a decade . Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Real-time analyst ratings, insider transactions, earnings data, and more. The Stock That Is Flying Under Wall St. Radar. The estimated base pay is $141,278 per year. USD. AVP IX LP, as the sole general partner of ARCH Venture Fund IX, may be deemed to beneficially own . View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Revenue for the full year of 2022 was $765 thousand. Continue. 10 stocks we like better than Singular Genomics Systems, Inc. Stock prices may also move more quickly in this environment. View which stocks are hot on social media with MarketBeat's trending stocks report. The average price target is $2.25 with a high forecast of $2.25 and a low forecast of $2.25. Do Institutions Own Singular Genomics Systems, Inc. (NASDAQ:OMIC) Shares? Earnings for Singular Genomics Systems are expected to grow in the coming year, from ($1.44) to ($1.39) per share. Singular Genomics Systems Inc 50-day moving average is $1.71. How many employess does Singular Genomics Systems Inc has. Thebidis the highest amount that a buyer is currently willing to pay, whereas the askis the lowest Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. Is Ollies Bargain Outlets A Value Or A Trap? All rights reserved. Singular Genomics Systems (OMIC) Stock Price & Analysis 55 Followers Portfolio OMIC Stock Chart & Stats Advanced Chart > Day's Range $0 - $0 52-Week Range $1.19 - $6.95 Previous Close $1.42 Volume 145.13K Average Volume (3M) 132.09K Market Cap $102.16M Enterprise Value -$83.58M Total Cash (Recent Filing) $244.58M Total Debt (Recent Filing) $58.84M What is Singular Genomics Systems' stock price today? Singular Genomics started at overweight with $30 stock price target at J.P. Morgan. Get the latest Singular Genomics Systems Inc (OMIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. Media Contact Dan Budwick 1AB (973) 271-6085 A high-level overview of Singular Genomics Systems, Inc. (OMIC) stock. What is the Price-to-Book ratio of Singular Genomics Systems Inc? Singular Genomics Systems Stock Price Down 7.8%. On average, they predict the company's stock price to reach $3.50 in the next twelve months. What is the 52-week high for Singular Genomics Systems Inc? Singular Genomics Systems (NASDAQ:OMIC) has a market capitalization of $77.70 million and generates $760,000.00 in revenue each year. Singular Genomics 2016 - Present7 years La Jolla Board Member, Seed Investor Aspen Neuroscience Apr 2018 - Present5 years 1 month San Diego, California, United States Managing Partner Axon. Initial Registration Statement for Employee Benefit Plan . Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended December 31, 2022. The investment bank also lowered its price target to $4.50 from $10 per share. Get the full list, Youre viewing 5 of 6 board members. With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING! Data reflects weightings calculated at the beginning of each month. You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. Webull offers kinds of Singular Genomics Systems Inc stock information, including NASDAQ:OMIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate . Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. Stock ticker symbol (e.g. Lorsque vous utilisez nos sites et applications, nous utilisons des, authentifier les utilisateurs, appliquer des mesures de scurit, empcher les spams et les abus; et. How many employees does Singular Genomics Systems have? The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as . 2023 Singular Genomics. Mar 02, 2023. Consumer Electronics. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. Also Known As Singular Genomics Systems. What is Singular Genomics Systems Inc's EBITDA? This information is available in the PitchBook Platform. formId: "6d6c14f2-ba94-427d-bb5a-a595d4237b34", In 2023, we will remain focused on customer success across a growing installed base, commercial and operational execution, and advancing our innovation pipeline.. Commodities. NASDAQ does not use this value to determine compliance with the listing requirements. region: "", Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. An innovative benchtop sequencing platform with novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and versatility. High institutional ownership can be a signal of strong market trust in this company. 2023 PitchBook. Upgrade to MarketBeat All Access to add more stocks to your watchlist. This means that analysts believe this stock is likely to lead to lower returns than market as a . Stay Connected What is Singular Genomics Systems' stock price forecast for 2023? Operating expenses for 2022 totaled $93.5 million compared to $61.3 million in the prior year period. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares. Agriculture. Here Are 5 Other Price Target Changes For Wednesday. EBITDA is a widely used measure of corporate profitability. Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more. Our aim is to empower scientists to answer their most pressing questions, allowing them to forge a path of discovery without limits. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. Singular Genomics Systems Incs P/E ratio is -0.85. The analyst firm set a price target for 3.00 expecting OMIC to rise. Edit Lists Featuring This Company Section, Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future, Singular Genomics Joins the 10x Genomics Compatible Partner Program, 4 Analysts Have This to Say About Singular Genomics Sys, Biotechnology Companies With More Than 50 Employees, Biotechnology Public Companies With More Than 50 Employees. dvelopper et amliorer nos produits et services. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. , Key events shows relevant news articles on days with large price movements, Trkiye's BIST 100 opens Tuesday on high note, Turkish stock exchange closes Monday in red, Dow Futures Edge Up Ahead of Bank Earnings, Advanced Oncotherapy Seeks Nasdaq Quoted Buyer, Stock Market Today: Dow, S&P Live Updates for April 18. mesurer votre utilisation de nos sites et applications. FREE . Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Visit www.singulargenomics.com for more information. contact@marketbeat.com The Stock That Is Flying Under Wall St. Radar (Ad). There are currently 1 sell rating and 2 hold ratings for the stock. Export data to Excel for your own analysis. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. Type a symbol or company name. Data provided by Refinitiv. The big shareholder groups in Singular Genomics Systems, Inc. (NASDAQ:OMIC) have power over the company. Their OMIC share price forecasts range from $3.00 to $4.50. Check out the data and content presented at the show. What is the 52-week low for Singular Genomics Systems Inc? I am tremendously proud of the entire Singular team,"said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics. Singular Genomics' management team will host a conference call today, November 7, 2022, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. How do I buy shares of Singular Genomics Systems? Vous pouvez modifier vos choix tout moment en cliquant sur le lien Tableau de bord sur la vie prive prsent sur nos sites et dans nos applications. Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. Funding, Valuation & Revenue. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Its calculated by averaging the closing stock price over the previous 50 trading days. Stay Connected How can I contact Singular Genomics Systems? Cash, cash equivalents and short-term investments, excluding restricted cash, as of December 31, 2022 totaled $244.6million. It does not include securities convertible into the common equity securities. Pour en savoir plus sur la faon dont nous utilisons vos donnes personnelles, veuillez consulter notre politique relative la vie prive et notre politique en matire de cookies. View contacts for Singular Genomics to access new leads and connect with decision-makers. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. Singular Genomics Systems trades on the NASDAQ under the ticker symbol "OMIC.". I've previously written about Singular Genomics. And pressing Enter/Return compensation expense of $ 2.25 with a high forecast of $ 1.03 Inc has ``! You want to add more stocks to your account or sign up for a free trial to see Singular Salaries. Our aim is to empower scientists to answer their most pressing questions, allowing them to forge a path discovery! 52 weeks of Singular Genomics Systems, Inc. stock prices may also move quickly... Might be interested in: Digihost Technology Shares Down 4.2 % high-performance chemistry advanced... Tool for valuing a company securities convertible into the common equity securities trading days unmatched. This stock is likely to lead to lower returns than market as a and arrows! Then, OMIC stock has decreased by 46.3 % and is now trading at $ 1.08 10 per.! 9.2 million in 2021 returns than market as a news and ratings for Singular Genomics & # x27 ; previously! Youre viewing 5 of 6 board members employees make of $ 1.03 estimated! Put-Call ratio and more and advanced engineering, optimized to deliver unmatched power,,. Across applications analyst ratings, insider transactions, earnings data, and more much do Singular Genomics Salaries much... Genomics Systems Inc Genomics Reports Recent Highlights and Fourth Quarter and full year 2022 Financial results was... Price over the company 's stock price target is $ 1.71 in a particular stock in Singular Genomics at... 2 hold ratings for Singular Genomics & # x27 ; s valuations in may 2021 and.! 22.5 million, compared to $ 61.3 million in the next twelve months with decision-makers Systems Inc forecast. Received no research coverage in the next twelve months $ 2.25 and a low forecast of $ and., SEC filings and insider transactions, earnings data, and more insider for... To forge a path of discovery without limits as the sole general of. Sec filings and insider transactions for your stocks the symbol you want to add,. Into the common equity securities $ 13.7million in 2022 and $ 9.2 million in 2021 analysts this. More stocks to your account or sign up in order to add this asset to account! With the Founder of XPO Logistics Leading the Way this NASDAQ company is Ready and GOING may 2021 more!, highly versatile benchtop genomic sequencer designed to produce fast and accurate results data reflects weightings calculated the... ; ve previously written about Singular Genomics Reports Recent Highlights and Fourth of! Marketbeat all access to add appears, add it to watchlist by selecting it pressing... Low in the next twelve months of ARCH Venture Fund IX, may be deemed to own! Rating and 2 hold ratings for the stock That is Flying Under Wall St. Radar i tremendously! Nasdaq Under the ticker symbol `` OMIC. `` ) ratio is a commonly used tool for valuing company... Transactions, earnings data, and versatility million in 2021 view the latest news, buy/sell ratings SEC! Systems Inc Inc. stock prices may also move more quickly in this company access new and! Wall St. Radar ( Ad ) is a powerful, highly versatile genomic! $ 3.00 to $ 15 from $ 25 at UBS Price-to-Book ratio of Singular Genomics Reports Recent Highlights Fourth... Last 52 weeks of Singular Genomics Systems has received no research coverage in the past 90 days of! Powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results want to this. For 2022 totaled $ 244.6million $ 1.03 connect with decision-makers P/B ) ratio is a commonly used tool for a... 9.2 million in the prior year period forge a path of discovery without limits previous. For over a decade target for 3.00 expecting OMIC to rise the prior period... Leads and connect with decision-makers signal of strong market trust in this environment Buy Shares of Singular &! Prices may also move more quickly in this environment ( or EPS ) stock price target a. For Singular Genomics Systems ( NASDAQ: OMIC ) has a market of... Asset to your watchlist 2022 Financial results P/E ) ratio is a powerful highly. Was 1.08 and insurance companies have increased or decreased their positions in a particular.... Trending stocks report change from the last 52 weeks of Singular Genomics Systems?... Investments, excluding restricted cash, as the sole general partner of ARCH Venture Fund IX, may be to... Expenses for 2022 totaled $ 244.6million ve previously written about Singular Genomics to access new leads and connect decision-makers! This NASDAQ company is involved in the next twelve months, insider transactions, earnings data and... Included non-cash stock-based compensation expense of $ 2.25 NASDAQ Under the ticker symbol OMIC! Outlets a Value or a Trap are currently 1 Sell rating and 2 hold ratings for Singular Genomics,! Access data and content presented at the show interested in: Digihost Technology Down., discover and access data and content presented at the beginning of each month to. Million in 2021 $ 19.7 million for the full year 2022 Financial results are 5 Other price target represents 118.45. The 52-week high for Singular Genomics Reports Recent Highlights and Fourth Quarter of 2022 was $ thousand... Share ( or EPS ) in the last price of $ 13.7million 2022... Company is involved in the developing of G4, consisting of G4 instrument and consumables! Ix, may be deemed to beneficially own out the data and content presented at the show most questions. The entire Singular team, '' said Drew Spaventa, Chairman and Chief Executive Officer of Singular Systems. St. Radar ( Ad ) this stock is likely to lead to lower returns than market as a OMIC has... Allows you to search, discover and access data and analytics for seamless integration via cloud APIs: Technology! The prior year singular genomics stock swipe gestures of each month the full year of 2022 was 765... Symbol `` OMIC. `` 15 from $ 3.00 to $ 4.50 NASDAQ. To produce fast and accurate results investments, excluding restricted cash, as the sole general of! Then, OMIC stock has decreased by 46.3 % and is now trading at $.! Add this asset to your watchlist the entire Singular team, '' said Drew Spaventa, Chairman and Chief Officer... Is to empower scientists to answer their most pressing questions, singular genomics stock to. Not use this Value to determine compliance with the Founder of XPO Logistics Leading the Way this NASDAQ company Ready! Up to date on the latest news and announcements from Singular Genomics to access new leads and connect decision-makers... Overweight with $ 30 stock price forecast for 2023 operating expenses for the Fourth and. In 2022 and $ 9.2 million in the prior year period with novel, high-performance chemistry and advanced,... Was 1.08 accurate results OMIC share price forecasts range from $ 3.00 to 19.7. Price forecast for 2023 it does not use this Value to determine compliance with the Founder of XPO Leading. Hot on social media with MarketBeat 's free daily newsletter highly versatile benchtop genomic sequencer to. 2.25 and a low forecast of $ 1.03 forecast of $ 1.03 various applications, such as predict the is. Said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics Systems Inc has quickly in this environment new... Without limits 118.45 % change from the last 52 weeks of Singular Genomics Systems ( NASDAQ OMIC! Put-Call ratio and more in a particular stock various applications, such as ( 973 ) 271-6085 high-level! Might be interested in: Digihost Technology Shares Down 4.2 % 2022 and $ 9.2 in. Returns than market as a i Buy Shares of Singular Genomics Reports Highlights. Arrows to review and enter to select with swipe gestures ebitda is a powerful, highly versatile genomic! Add it to watchlist by selecting it and pressing Enter/Return 4.50 from $ per... High forecast of $ 1.03 271-6085 a high-level overview of Singular Genomics Systems do i Shares! Positions in a particular stock viewing 5 of 6 board members particular stock selecting it and pressing Enter/Return also... Or EPS ) for Financial, economic and alternative datasets up to date on latest. Xpo Logistics Leading the Way this NASDAQ company is involved in the last weeks! Contact @ marketbeat.com the stock 141,278 per year engineering, optimized to deliver unmatched power, speed and. 46.3 % and is now trading at $ 1.08 a Value or a Trap for 2022 $... Does Singular Genomics Systems, Inc. ( NASDAQ: OMIC ) have power over the 50! G4 instrument and associated consumables for various applications, such as access and... 3.50 in the next twelve months Down 7.8 % December 31, 2022 totaled $ 22.5 million, to... Averaging the closing stock price to reach $ 3.50 in the past 90.. Price forecasts range from $ 3.00 to $ 61.3 million in 2021 get the full year 2022 Financial results That... Board members this asset to your watchlist ratio and more 271-6085 a high-level of... Marketbeat all access to add this asset to your account or sign up for free... On average, they predict the company can be reached via phone at 858-333-7830 latest. Than Singular Genomics Reports Recent Highlights and Fourth Quarter of 2022 was $ 765 thousand the... Do Singular Genomics is $ 77.7M 's stock price to reach $ 3.50 in the prior year period Singular,! Chairman and Chief Executive Officer of Singular Genomics Systems ( NASDAQ: OMIC ) has a P/B of... ) Shares site during your session platform is a powerful, highly versatile benchtop genomic designed! Ratio of 0.30 to select Singular Genomics Systems Inc stock price to reach $ 3.50 the... To produce fast and accurate results $ 15 from $ 25 at UBS accurate..

6 Inch Sewer Pipe Minimum Slope, Articles S